Literature DB >> 9067543

Histomorphological and immunohistochemical characterization of colonic aberrant crypt foci in rats: relationship to growth factor expression.

I Thorup1.   

Abstract

Many studies have been conducted to assess the potential preneoplastic nature of colonic aberrant crypt foci (ACF), but still the biological significance of these foci and their relationship to colon neoplasia remains to be elucidated. In the present paper a battery of variables suggested to be indicative for colon cancer development has been studied in relation to ACF in rats. These include: (i) the degree of dysplasia; (ii) the type of mucus production; (iii) the cellular immunohistochemical expression and distribution of transforming growth factors alpha and beta and their respective receptors, epidermal growth factor receptor and transforming growth factor beta receptors I and II and phosphorylated cellular tyrosine. The parameters have been investigated in ACF selected from a previous study where the foci were induced under different circumstances, leading to disparities in the number as well as the crypt multiplicity obtained. The present study showed that for all parameters investigated, apart from sialomucin production, the different experimental conditions had no effect on the individual ACF, irrespective of the number and distribution of the different categories of ACF among the various diets. However, it was shown that the degree of dysplasia correlated strongly with crypt multiplicity and that all the investigated ACF lacked expression of transforming growth factor alpha and expressed a reduced amount of transforming growth factor beta compared with normal crypts. These observations may indicate that ACF are preneoplastic lesions and supports the suggestion that they may, at least in the rat, have the potential to gradually progress to tumors, but no single ACF showed particular characteristics indicating specific proneness to tumor development. The study could not confirm the presence of sialomucin-producing ACF as a valid marker for tumor development.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9067543     DOI: 10.1093/carcin/18.3.465

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  7 in total

Review 1.  Aberrant crypt foci as microscopic precursors of colorectal cancer.

Authors:  Lei Cheng; Mao-De Lai
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

2.  Comparative DNA adduct formation and induction of colonic aberrant crypt foci in mice exposed to 2-amino-9H-pyrido[2,3-b]indole, 2-amino-3,4-dimethylimidazo[4,5-f]quinoline, and azoxymethane.

Authors:  Sangyub Kim; Jingshu Guo; M Gerald O'Sullivan; Daniel D Gallaher; Robert J Turesky
Journal:  Environ Mol Mutagen       Date:  2016-01-06       Impact factor: 3.216

3.  Aberrant crypt foci and AgNORs as putative biomarkers to evaluate the chemopreventive efficacy of pronyl-lysine in rat colon carcinogenesis.

Authors:  Jayabal Panneer Selvam; Selvaraj Aranganathan; Namasivayam Nalini
Journal:  Invest New Drugs       Date:  2008-02-29       Impact factor: 3.850

Review 4.  Morphological and molecular alterations in 1,2 dimethylhydrazine and azoxymethane induced colon carcinogenesis in rats.

Authors:  Martina Perše; Anton Cerar
Journal:  J Biomed Biotechnol       Date:  2010-12-28

5.  Azoxymethane-Induced Colorectal Cancer Mice Treated with a Polyphenol-Rich Apple Extract Show Less Neoplastic Lesions and Signs of Cachexia.

Authors:  Florencio Marzo; Fermin I Milagro; Jaione Barrenetxe; María Teresa Díaz; J Alfredo Martínez
Journal:  Foods       Date:  2021-04-15

6.  Cyclophilin C-associated protein (CyCAP) knock-out mice spontaneously develop colonic mucosal hyperplasia and exaggerated tumorigenesis after treatment with carcinogen azoxymethane.

Authors:  Emina Emilia Torlakovic; Vicki Keeler; Chang Wang; Hyun J Lim; Leslie Ann Lining; Suzanne Laferté
Journal:  BMC Cancer       Date:  2009-07-24       Impact factor: 4.430

Review 7.  Colon preneoplastic lesions in animal models.

Authors:  Masumi Suzui; Takamitsu Morioka; Naoki Yoshimi
Journal:  J Toxicol Pathol       Date:  2013-12-26       Impact factor: 1.628

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.